Sanger DNA sequencing, also known as chain termination sequencing, is a method for determining the nucleotide sequence of DNA. Developed by Frederick Sanger and his colleagues in 1977, this technique revolutionized molecular biology by providing a relatively simple and reliable way to read the genetic code. It served as the foundation for much of modern genomics and was the primary method used during the Human Genome Project.
Despite newer technologies emerging, Sanger sequencing remains widely used due to its accuracy, especially for sequencing small DNA fragments, validating next-generation sequencing results, and clinical diagnostics.
The core idea behind Sanger sequencing involves the selective incorporation of chain-terminating dideoxynucleotides (ddNTPs) during DNA synthesis. These modified nucleotides lack the 3 hydroxyl group required to form phosphodiester bonds, causing DNA strand extension to stop once they are incorporated.
By setting up a DNA synthesis reaction with a mixture of normal nucleotides (dNTPs) and small amounts of fluorescently labeled ddNTPs for each of the four bases (A, T, C, G), the process generates DNA fragments of varying lengths. Each fragment ends at the point where a ddNTP was incorporated, representing a specific base. By separating these fragments by size, and detecting the fluorescent labels, the original DNA sequence can be inferred.
The DNA to be sequenced must first be purified and rendered single-stranded. The primer is designed to complement a known region of the single-stranded DNA template and is generally around 18-25 nucleotides long. It provides a free 3' hydroxyl group from which DNA polymerase can start DNA synthesis.
The reaction mixture contains the single-stranded DNA template, primer, DNA polymerase, all four regular dNTPs, and a small amount of each ddNTP (each labeled with a different fluorescent dye) in one combined reaction. The ratio of ddNTP to dNTP is critical; too many ddNTPs would lead to mostly short fragments, while too few would reduce termination events.
The DNA polymerase extends the primer by adding complementary nucleotides. Occasionally, in place of a regular dNTP, a ddNTP is incorporated. Because ddNTPs lack the 3 OH, the chain cannot be extended further, resulting in fragments of differing lengths, each terminating at a position corresponding to a specific base.
The resulting labeled DNA fragments are separated by size via capillary electrophoresis. Smaller fragments migrate faster than longer ones. As fragments pass a detector, the fluorescent dye attached to the terminal ddNTP is excited by a laser, and the emitted fluorescence is recorded.
Specialized software reads the order of colored fluorescent peaks from the electropherogram and translates this into the sequence of the DNA template. The sequence is typically read from shortest fragment (closest to primer) to longest.
Sanger sequencing is still widely used in molecular biology and genetics for:
Frederick Sangers discovery of this method earned him his second Nobel Prize in Chemistry in 1980. It paved the way for genetic engineering, biotechnology, and genomics. The Human Genome Project, launched in the 1990s, relied heavily on Sanger sequencing to map the entire human genetic code.
While newer methods like Illumina sequencing and nanopore sequencing have largely replaced it in high-throughput sequencing, Sanger sequencing remains the final verification tool for sequence accuracy.
Sanger DNA sequencing is a foundational DNA sequencing technique that uses labeled dideoxynucleotides to produce truncated DNA fragments for sequence determination. Its methodical approach has enabled detailed genetic analysis for decades and continues to have valuable roles in research and clinical diagnostics. Its balance of accuracy and simplicity guarantees it a lasting place in molecular biology.
